We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
-15.01%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$461M
AUM Growth
-$222M
Cap. Flow
-$108M
Cap. Flow %
-23.46%
Top 10 Hldgs %
59.88%
Holding
143
New
25
Increased
20
Reduced
27
Closed
54

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$24.9M
2
VTRS icon
Viatris
VTRS
+$13.9M
3
ITRN icon
Ituran Location and Control
ITRN
+$8.4M
4
PFE icon
Pfizer
PFE
+$7.53M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$4.18M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$21.4M
2
BMY icon
Bristol-Myers Squibb
BMY
+$8.36M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.09M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.76M
5
INCY icon
Incyte
INCY
+$5.6M

Sector Composition

Rank Sector Weight
1 Healthcare 62.23%
2 Technology 3.77%
3 Utilities 2.89%
4 Communication Services 2.27%
5 Financials 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLV icon
1
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
$50.8M 11.02%
+750,000
New +$50.2M
PFE icon
2
Pfizer
PFE
$143B
$42.3M 9.17%
1,503,649
+263,500
+21% +$7.53M
TEVA icon
3
Teva Pharmaceuticals
TEVA
$40.8B
$38.8M 8.41%
725,200
-59,650
-8% -$3.5M
BIIB icon
4
Biogen
BIIB
$30B
$30.9M 6.71%
118,850
-5,000
-4% -$1.32M
OEF icon
5
PUT
iShares S&P 100 ETF
OEF
$20.1B
$27.7M 5.99%
+250,000
New +$21.8M
AGN
6
DELISTED
Allergan plc
AGN
$26.8M 5.81%
100,000
– –
SHPG
7
DELISTED
Shire pic
SHPG
$16.5M 3.57%
188,676
+148,676
+372% +$24.9M
GILD icon
8
Gilead Sciences
GILD
$162B
$15.9M 3.44%
172,700
+30,000
+21% +$2.71M
VTRS icon
9
Viatris
VTRS
$20.4B
$13.3M 2.89%
+287,827
New +$13.9M
ORA icon
10
Ormat Technologies
ORA
$6B
$13.3M 2.88%
322,193
+49,731
+18% +$1.85M
CELG
11
DELISTED
Celgene Corp
CELG
$10M 2.17%
100,000
-47,200
-32% -$4.86M
ITRN icon
12
Ituran Location and Control
ITRN
$1.09B
$9.28M 2.01%
+471,584
New +$8.4M
ALXN
13
DELISTED
Alexion Pharmaceuticals
ALXN
$5.57M 1.21%
40,000
-19,164
-32% -$2.81M
V icon
14
Visa
V
$684B
$5.15M 1.12%
67,369
+30,769
+84% +$2.24M
XLF icon
15
PUT
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
$4.5M 0.98%
+227,829
New +$4.34M
ALNY icon
16
Alnylam Pharmaceuticals
ALNY
$27.5B
$4.39M 0.95%
70,000
+30,000
+75% +$1.99M
GOOGL icon
17
Alphabet (Google) Class A
GOOGL
$4.36T
$4.33M 0.94%
+113,600
New +$4.18M
VNDA icon
18
Vanda Pharmaceuticals
VNDA
$307M
$4.28M 0.93%
512,051
+50,000
+11% +$410K
ACAD icon
19
Acadia Pharmaceuticals
ACAD
$4.43B
$4.19M 0.91%
150,000
+50,000
+50% +$1.09M
SAGE
20
DELISTED
Sage Therapeutics
SAGE
$3.94M 0.85%
123,000
+30,000
+32% +$1.06M
ADMS
21
DELISTED
Adamas Pharmaceuticals
ADMS
$3.9M 0.85%
270,000
+120,000
+80% +$2.02M
FPRX
22
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$3.25M 0.7%
80,000
-65,000
-45% -$2.23M
ESLT icon
23
Elbit Systems
ESLT
$37.9B
$3.24M 0.7%
+34,456
New +$2.96M
AAP icon
24
Advance Auto Parts
AAP
$3.35B
$3.23M 0.7%
20,136
+4,581
+29% +$689K
CHTR icon
25
Charter Communications
CHTR
$17.3B
$3.23M 0.7%
15,930
+11,904
+296% +$2.14M
1
2 3 4 5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q1 2016 Portfolio in Review

As of Q1 2016, Sphera Funds Management held 143 positions worth $461M, down 32% from $683M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Sphera Funds Management withdrew a net $108M in Q1 2016, closing 54 positions and reducing 27 holdings. Its most notable exit was AbbVie, an estimated $21.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 61% a quarter earlier, followed by Technology and Utilities.

Against the trend, Sphera Funds Management opened a new position in Viatris worth $13.3M.

  • Sphera Funds Management's largest Q1 2016 buy was Viatris: 287,827 shares worth $13.3M.
  • Sphera Funds Management added most to Shire pic in Q1 2016, an estimated $24.9M increase.
  • Sphera Funds Management's biggest Q1 2016 reduction was Celgene Corp, cutting an estimated $4.86M.
  • Sphera Funds Management fully exited AbbVie in Q1 2016, selling an estimated $21.4M.
  • Sphera Funds Management's ten largest holdings make up 60% of its $461M portfolio in Q1 2016.
  • Sphera Funds Management opened 25 new positions and closed 54 in Q1 2016.
  • Sphera Funds Management's portfolio value fell 32% quarter-over-quarter to $461M.

Based on Sphera Funds Management's 13F filing for Q1 2016, filed 16 May 2016.